Treatment with Tau fibrils impact Huntington's disease-related phenotypes in cell and mouse models
Shireen Salem(Université Laval), Francesca Cicchetti(Centre hospitalier universitaire de Québec)
Cited by 2
Related Papers
The contribution of inflammatory astrocytes to BBB impairments in a brain-chip model of Parkinson’s disease
|Nature Communications|2023|109
Mapping of brain function after MPTP-induced neurotoxicity in a primate Parkinson's disease model
|NeuroImage|2003|54
Outcome of cell suspension allografts in a patient with Huntington's disease
|Annals of Neurology|2018|24
Erythrocyte-derived extracellular vesicles transcytose across the blood-brain barrier to induce Parkinson’s disease-like neurodegeneration
|Fluids and Barriers of the CNS|2025|7